FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Alexa, Tell Me About MS: VIDEO





























Alexa, Amazon’s little voice-activated information box, has just received a multiple sclerosis infusion.

As part of MS Awareness Month, fifty facts about MS have been loaded into Alexa’s memory. If a user says “Alexa, start MS Awareness” the system will respond with a random MS fact. (And a short commercial message for drug maker Acorda).

Acorda Therapeutics, which makes the MS drugs Ampyra, Zanaflex and Qutenza, developed this “skill” for Amazon.  The “skill” draws its content from Acorda’s MS Self app, which is designed to help you manage your MS. On it you can record your symptoms, mood, energy level, mobility and activity. You can then generate reports to see how, over time, you’re doing. The app also has the ability to sync with a Fitbit and includes real-time weather information.

“Education is an important component of each person’s fight against multiple sclerosis,” says Acorda executive Michael Russo. “As we move towards becoming an increasingly digital society, it’s important that we provide solutions that match the way people live and work, and in this case that means voice search.”

Other apps that can help you manage your MS:

My Sidekick, by drug maker Biogen (Avonex, Tysabri, Tecfidera and others), is similar to the MS Self app. It offers a daily overview, tips to help you as you live with MS, and customized reminders that help you remember to use your trackers, take your medicine, and keep your doctor appointments. It also includes a built-in step tracker (to use with an iPhone 5s or later model) and a list of suggested questions to ask at your next doctor appointment to help you have more productive conversations. As someone who always forgets to ask something, I really like that feature.

My MS Manager, from the Multiple Sclerosis Association of America. This one is available for both iOS and Android devices. It tracks your disease activity, stores medical information, and generates charts and reports for various metrics, such as treatments, moods, symptoms and more.

MS Buddy, from Healthline, matches you with other MS patients so you can share experiences. You provide your age, gender, location, type of MS, treatment, medication, and how long you’ve had multiple sclerosis. Then, each day, the app matches you with another user with a similar profile. Reach out to that person or not, it’s your choice.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News